164 related articles for article (PubMed ID: 21969818)
1. Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.
Lu H; Liu P; Pan Y; Huang H
Neoplasia; 2011 Sep; 13(9):854-63. PubMed ID: 21969818
[TBL] [Abstract][Full Text] [Related]
2. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
Liu P; Kao TP; Huang H
Oncogene; 2008 Aug; 27(34):4733-44. PubMed ID: 18408765
[TBL] [Abstract][Full Text] [Related]
3. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.
Huang H; Regan KM; Lou Z; Chen J; Tindall DJ
Science; 2006 Oct; 314(5797):294-7. PubMed ID: 17038621
[TBL] [Abstract][Full Text] [Related]
4. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons.
Yuan Z; Becker EB; Merlo P; Yamada T; DiBacco S; Konishi Y; Schaefer EM; Bonni A
Science; 2008 Mar; 319(5870):1665-8. PubMed ID: 18356527
[TBL] [Abstract][Full Text] [Related]
5. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
Gheghiani L; Shang S; Fu Z
Sci Rep; 2020 Jul; 10(1):12327. PubMed ID: 32704044
[TBL] [Abstract][Full Text] [Related]
6. Long‑term exposure to leptin enhances the growth of prostate cancer cells.
Noda T; Kikugawa T; Tanji N; Miura N; Asai S; Higashiyama S; Yokoyama M
Int J Oncol; 2015 Apr; 46(4):1535-42. PubMed ID: 25625287
[TBL] [Abstract][Full Text] [Related]
7. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
[TBL] [Abstract][Full Text] [Related]
8. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
Bohrer LR; Liu P; Zhong J; Pan Y; Angstman J; Brand LJ; Dehm SM; Huang H
Prostate; 2013 Jul; 73(10):1017-27. PubMed ID: 23389878
[TBL] [Abstract][Full Text] [Related]
9. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
Liu P; Li S; Gan L; Kao TP; Huang H
Cancer Res; 2008 Dec; 68(24):10290-9. PubMed ID: 19074897
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
12. Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition.
Flores O; Wang Z; Knudsen KE; Burnstein KL
Endocrinology; 2010 Mar; 151(3):896-908. PubMed ID: 20147522
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.
Chen S; Xu Y; Yuan X; Bubley GJ; Balk SP
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15969-74. PubMed ID: 17043241
[TBL] [Abstract][Full Text] [Related]
15. AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins.
Saline M; Badertscher L; Wolter M; Lau R; Gunnarsson A; Jacso T; Norris T; Ottmann C; Snijder A
J Biol Chem; 2019 Aug; 294(35):13106-13116. PubMed ID: 31308176
[TBL] [Abstract][Full Text] [Related]
16. Differential response of glioma cells to FOXO1-directed therapy.
Lau CJ; Koty Z; Nalbantoglu J
Cancer Res; 2009 Jul; 69(13):5433-40. PubMed ID: 19549905
[TBL] [Abstract][Full Text] [Related]
17. Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer.
Ma L; Yan Y; Bai Y; Yang Y; Pan Y; Gang X; Karnes RJ; Zhang J; Lv Q; Wu Q; Huang H
Theranostics; 2019; 9(17):5020-5034. PubMed ID: 31410199
[No Abstract] [Full Text] [Related]
18. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
[TBL] [Abstract][Full Text] [Related]
19. Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.
Moore NL; Weigel NL
Int J Biochem Cell Biol; 2011 Aug; 43(8):1157-67. PubMed ID: 21550420
[TBL] [Abstract][Full Text] [Related]
20. CDK2 and FOXO1: a fork in the road for cell fate decisions.
Huang H; Tindall DJ
Cell Cycle; 2007 Apr; 6(8):902-6. PubMed ID: 17457058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
